XML 112 R69.htm IDEA: XBRL DOCUMENT v3.25.4
Restructuring - Narrative (Details)
$ in Millions
12 Months Ended
Dec. 31, 2025
USD ($)
employee
Dec. 31, 2023
USD ($)
Mar. 31, 2025
ft²
Sep. 30, 2023
ft²
Restructuring Cost and Reserve [Line Items]        
Operating lease area | ft²     580,000  
Reata Pharmaceuticals, Inc        
Restructuring Cost and Reserve [Line Items]        
Operating lease area | ft²       327,400
Operating lease, contract term       16 years
Minimum        
Restructuring Cost and Reserve [Line Items]        
Expected cost remaining $ 320.0      
Operating lease, contract term 1 year      
2023 Cost Saving Initiatives        
Restructuring Cost and Reserve [Line Items]        
Expected operating expense reduction   $ 1,000.0    
Expected number of positions eliminated | employee 1,400      
Reata Integration        
Restructuring Cost and Reserve [Line Items]        
Expected cost $ 35.0